Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-22

Clinical Trial Update: Effect of Sumatriptan on Levcromakalim-Induced Symptoms in Individuals With Migraine [NA]

View source ↗

Summary

A clinical trial evaluated whether sumatriptan affects levcromakalim-induced symptoms in people with migraine, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levcromakalim (levcromakalim)
  • Sumatriptan (Sumatriptan)

Snippet

Sponsor: Danish Headache Center | Conditions: Migraine Without Aura, Headache | NA | Status: COMPLETED